Aortic dissection in a patient treated by sunitinib for metastatic renal cell carcinoma

Ann Oncol. 2010 Jan;21(1):186-7. doi: 10.1093/annonc/mdp480. Epub 2009 Oct 29.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antihypertensive Agents / therapeutic use
  • Antineoplastic Agents / adverse effects*
  • Aortic Aneurysm / chemically induced*
  • Aortic Aneurysm / pathology
  • Aortic Dissection / chemically induced*
  • Aortic Dissection / pathology
  • Carcinoma, Renal Cell / drug therapy
  • Carcinoma, Renal Cell / secondary
  • Carcinoma, Renal Cell / surgery
  • Combined Modality Therapy
  • Humans
  • Hypertension / complications
  • Hypertension / drug therapy
  • Indoles / adverse effects*
  • Kidney Neoplasms / drug therapy
  • Kidney Neoplasms / pathology
  • Kidney Neoplasms / surgery
  • Lung Neoplasms / secondary
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Nephrectomy
  • Pyrroles / adverse effects*
  • Sirolimus / analogs & derivatives
  • Sirolimus / therapeutic use
  • Sunitinib

Substances

  • Antihypertensive Agents
  • Antineoplastic Agents
  • Indoles
  • Pyrroles
  • temsirolimus
  • Sunitinib
  • Sirolimus